| Type | Title | Date Released | |
|---|---|---|---|
425 | Form 425 | ||
8-K | Drugs Made In America Acquisition Corp. Amends Merger Agreement with Power Analytics Global Corp. and Updates Valuation Terms | ||
425 | Form 425 | ||
8-K | Drugs Made In America Acquisition Corp. Enters Into Amended Merger Agreement with Power Analytics Global Corp | ||
10-Q | Form 10-Q | ||
SCHEDULE 13G/A | Karpus Management, Inc. (Filed by) | ||
SCHEDULE 13G/A | First Trust Capital Management L.P. (Filed by) | ||
SCHEDULE 13G/A | GLAZER CAPITAL, LLC (Filed by) | ||
SCHEDULE 13G/A | MIZUHO FINANCIAL GROUP INC (Filed by) | ||
425 | Form 425 | ||
8-K | Drugs Made In America Acquisition Corp. Announces Third Amendment to Merger Agreement with Power Analytics Global Corp. | ||
SCHEDULE 13G | Feis Equities LLC (Filed by) |
